130 related articles for article (PubMed ID: 11595290)
1. Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys.
Barouch DH; Fu TM; Montefiori DC; Lewis MG; Shiver JW; Letvin NL
Immunol Lett; 2001 Nov; 79(1-2):57-61. PubMed ID: 11595290
[TBL] [Abstract][Full Text] [Related]
2. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.
Barouch DH; Santra S; Schmitz JE; Kuroda MJ; Fu TM; Wagner W; Bilska M; Craiu A; Zheng XX; Krivulka GR; Beaudry K; Lifton MA; Nickerson CE; Trigona WL; Punt K; Freed DC; Guan L; Dubey S; Casimiro D; Simon A; Davies ME; Chastain M; Strom TB; Gelman RS; Montefiori DC; Lewis MG; Emini EA; Shiver JW; Letvin NL
Science; 2000 Oct; 290(5491):486-92. PubMed ID: 11039923
[TBL] [Abstract][Full Text] [Related]
3. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
[TBL] [Abstract][Full Text] [Related]
4. Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates.
Bertley FM; Kozlowski PA; Wang SW; Chappelle J; Patel J; Sonuyi O; Mazzara G; Montefiori D; Carville A; Mansfield KG; Aldovini A
J Immunol; 2004 Mar; 172(6):3745-57. PubMed ID: 15004179
[TBL] [Abstract][Full Text] [Related]
5. Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.
Barouch DH; Santra S; Kuroda MJ; Schmitz JE; Plishka R; Buckler-White A; Gaitan AE; Zin R; Nam JH; Wyatt LS; Lifton MA; Nickerson CE; Moss B; Montefiori DC; Hirsch VM; Letvin NL
J Virol; 2001 Jun; 75(11):5151-8. PubMed ID: 11333896
[TBL] [Abstract][Full Text] [Related]
6. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
7. Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques.
Amara RR; Ibegbu C; Villinger F; Montefiori DC; Sharma S; Nigam P; Xu Y; McClure HM; Robinson HL
Virology; 2005 Dec; 343(2):246-55. PubMed ID: 16185742
[TBL] [Abstract][Full Text] [Related]
8. Protection by dendritic cells-based HIV synthetic peptide cocktail vaccine: preclinical studies in the SHIV-rhesus model.
Nehete PN; Nehete BP; Manuri P; Hill L; Palmer JL; Sastry KJ
Vaccine; 2005 Mar; 23(17-18):2154-9. PubMed ID: 15755586
[TBL] [Abstract][Full Text] [Related]
9. Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.
Mooij P; Nieuwenhuis IG; Knoop CJ; Doms RW; Bogers WM; Ten Haaft PJ; Niphuis H; Koornstra W; Bieler K; Köstler J; Morein B; Cafaro A; Ensoli B; Wagner R; Heeney JL
J Virol; 2004 Apr; 78(7):3333-42. PubMed ID: 15016855
[TBL] [Abstract][Full Text] [Related]
10. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
[TBL] [Abstract][Full Text] [Related]
11. Preventing AIDS but not HIV-1 infection with a DNA vaccine.
Shen X; Siliciano RF
Science; 2000 Oct; 290(5491):463-5. PubMed ID: 11183769
[TBL] [Abstract][Full Text] [Related]
12. A noninfectious simian/human immunodeficiency virus DNA vaccine that protects macaques against AIDS.
Singh DK; Liu Z; Sheffer D; Mackay GA; Smith M; Dhillon S; Hegde R; Jia F; Adany I; Narayan O
J Virol; 2005 Mar; 79(6):3419-28. PubMed ID: 15731236
[TBL] [Abstract][Full Text] [Related]
13. An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants.
Rose NF; Marx PA; Luckay A; Nixon DF; Moretto WJ; Donahoe SM; Montefiori D; Roberts A; Buonocore L; Rose JK
Cell; 2001 Sep; 106(5):539-49. PubMed ID: 11551502
[TBL] [Abstract][Full Text] [Related]
14. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
15. Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.
Egan MA; Charini WA; Kuroda MJ; Schmitz JE; Racz P; Tenner-Racz K; Manson K; Wyand M; Lifton MA; Nickerson CE; Fu T; Shiver JW; Letvin NL
J Virol; 2000 Aug; 74(16):7485-95. PubMed ID: 10906202
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.
Barouch DH; Craiu A; Kuroda MJ; Schmitz JE; Zheng XX; Santra S; Frost JD; Krivulka GR; Lifton MA; Crabbs CL; Heidecker G; Perry HC; Davies ME; Xie H; Nickerson CE; Steenbeke TD; Lord CI; Montefiori DC; Strom TB; Shiver JW; Lewis MG; Letvin NL
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4192-7. PubMed ID: 10759543
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
Enose Y; Kita M; Yamamoto T; Suzuki H; Miyake A; Horiuchi R; Ibuki K; Kaneyasu K; Kuwata T; Takahashi E; Sakai K; Shinohara K; Miura T; Hayami M
Arch Virol; 2004 Sep; 149(9):1705-20. PubMed ID: 15593414
[TBL] [Abstract][Full Text] [Related]
18. Immunization of macaques with live simian human immunodeficiency virus (SHIV) vaccines conferred protection against AIDS induced by homologous and heterologous SHIVs and simian immunodeficiency virus.
Kumar A; Mukherjee S; Shen J; Buch S; Li Z; Adany I; Liu Z; Zhuge W; Piatak M; Lifson J; McClure H; Narayan O
Virology; 2002 Sep; 301(2):189-205. PubMed ID: 12359422
[TBL] [Abstract][Full Text] [Related]
19. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239.
Horton H; Vogel TU; Carter DK; Vielhuber K; Fuller DH; Shipley T; Fuller JT; Kunstman KJ; Sutter G; Montefiori DC; Erfle V; Desrosiers RC; Wilson N; Picker LJ; Wolinsky SM; Wang C; Allison DB; Watkins DI
J Virol; 2002 Jul; 76(14):7187-202. PubMed ID: 12072518
[TBL] [Abstract][Full Text] [Related]
20. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]